IMA Talks https://www.bingepods.com en ImaTalks by AMI Polymer is where science meets innovation. Hosted by Khushi Gandhi, this thought-leadership podcast brings together leading voices from the biotechnology industry. Each episode explores groundbreaking innovations, emerging market opportunities, and the personal journeys of industry experts—offering fresh perspectives on how biotech is shaping the future.   01:10:22 Final Thoughts and Advice https://megaphone.imgix.net/podcasts/bb3b9b48-8fd0-11f0-be0d-336ff692f25b/image/231c01b2bf47e3066a57ea1bf2d56443.png?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress IMA Talks https://www.bingepods.com episodic Resourceful Influencing AMI Polymers ImaTalks by AMI Polymer is where science meets innovation. Hosted by Khushi Gandhi, this thought-leadership podcast brings together leading voices from the biotechnology industry. Each episode explores groundbreaking innovations, emerging market opportunities, and the personal journeys of industry experts—offering fresh perspectives on how biotech is shaping the future.   01:10:22 Final Thoughts and Advice ImaTalks by AMI Polymer is where science meets innovation. Hosted by Khushi Gandhi, this thought-leadership podcast brings together leading voices from the biotechnology industry. Each episode explores groundbreaking innovations, emerging market opportunities, and the personal journeys of industry experts—offering fresh perspectives on how biotech is shaping the future.

  01:10:22 Final Thoughts and Advice

]]> Bingepods studio@ideabrews.com From Malaria Coma to Vaccine Vision: Dr. Priyabrata Pattnaik on Healthcare Preparedness In this powerful episode of IMA TALKS, host Khushi Gandhi sits down with Dr. Priyabrata Pattnaik, CEO of Ami Polymer and a veteran in infectious disease research, bioprocessing, and vaccine development. From surviving cerebral malaria and a life-changing coma at 19 in a remote tribal area, to leading critical components manufacturing for global biologics, Dr. Pattnaik shares a deeply personal and insightful journey at the intersection of science, resilience, and real-world impact. Key Highlights: • His near-death experience with malaria and why access to healthcare — especially the "last mile" — remains one of the biggest challenges in global health • The evolution of vaccine platforms (from traditional inactivated vaccines to mRNA), manufacturing scale-up hurdles, purification challenges, and what truly drives vaccine costs • Lessons from Ebola, COVID-19, and Disease X: Why in-country capacity, supply chain resilience, and balancing emergency response with routine immunization are critical for future preparedness • Leadership wisdom for scientists and young professionals: The power of curiosity, asking "why," embracing gray spaces in decision-making, and staying true to your North Star Dr. Pattnaik also discusses Atmanirbhar Bharat’s role in vaccine self-reliance, the promise and realities of new technologies, and practical advice for the next generation entering life sciences. Whether you're a healthcare professional, student, policymaker, or simply curious about how science turns into lifesaving impact, this conversation offers profound takeaways on innovation, equity, and preparedness. 🎧 Listen now and discover what it really takes to build resilient health systems. If you enjoyed this episode, like, subscribe to IMA Talks for more conversations where science meets story, and share it with someone passionate about healthcare and innovation. Turn on notifications so you never miss an episode! 00:00 Coma Survivor Story 00:25 Ebola Preparedness Reality 00:50 Curiosity And Risk 01:39 Show Intro And Guest 03:11 Near Death Malaria Lessons 05:16 How Vaccines Work 07:20 Why Malaria Vaccine Hard 09:40 Vaccine Platforms Evolution 12:00 mRNA Breakthrough Limits 13:40 Scaling Lab To Factory 15:59 Vaccine Supply Chain Map 19:16 Purification Cost Challenge 21:16 Quality By Design GMP 23:21 What Drives Vaccine Cost 24:44 Indigenous Manufacturing Push 28:45 Innovation Needs Buyers 30:11 Pandemic Supply Chain Gaps 33:08 Outbreak Response Together 34:19 Ebola Systems Not Just Vaccine 37:29 Cold Chain Never Break 38:34 Myth And Supply Chain 38:51 Rapid Fire Vaccine Takes 39:56 Purpose And The Five Whys 42:15 Politics And Vaccine Access 43:47 Disease X And Unknown Threats 44:49 Zero Dose Immunization Gap 46:50 Innovation Versus Last Mile 49:11 India Asia Manufacturing Rise 50:52 Tech Transfer Trust Explained 54:06 Future Of Biomanufacturing 55:53 Leading In Gray Space 01:03:17 Gen Z Purpose Discipline 01:05:32 Read Rooms Fix Systems 01:08:49 Ambi Polymer Healthcare Vision 01:11:03 Final Advice And Farewell #Vaccines #HealthcareInnovation #PandemicPreparedness #Biologics #imatalks Visit our social media pages: LinkedIn:   / published   Instagram:   / amipolymer   Sat, 20 Jun 2026 06:30:00 -0000 full AMI Polymers In this powerful episode of IMA TALKS, host Khushi Gandhi sits down with Dr. Priyabrata Pattnaik, CEO of Ami Polymer and a veteran in infectious disease research, bioprocessing, and vaccine development. From surviving cerebral malaria and a life-changing coma at 19 in a remote tribal area, to leading critical components manufacturing for global biologics, Dr. Pattnaik shares a deeply personal and insightful journey at the intersection of science, resilience, and real-world impact. Key Highlights: • His near-death experience with malaria and why access to healthcare — especially the "last mile" — remains one of the biggest challenges in global health • The evolution of vaccine platforms (from traditional inactivated vaccines to mRNA), manufacturing scale-up hurdles, purification challenges, and what truly drives vaccine costs • Lessons from Ebola, COVID-19, and Disease X: Why in-country capacity, supply chain resilience, and balancing emergency response with routine immunization are critical for future preparedness • Leadership wisdom for scientists and young professionals: The power of curiosity, asking "why," embracing gray spaces in decision-making, and staying true to your North Star Dr. Pattnaik also discusses Atmanirbhar Bharat’s role in vaccine self-reliance, the promise and realities of new technologies, and practical advice for the next generation entering life sciences. Whether you're a healthcare professional, student, policymaker, or simply curious about how science turns into lifesaving impact, this conversation offers profound takeaways on innovation, equity, and preparedness. 🎧 Listen now and discover what it really takes to build resilient health systems. If you enjoyed this episode, like, subscribe to IMA Talks for more conversations where science meets story, and share it with someone passionate about healthcare and innovation. Turn on notifications so you never miss an episode! 00:00 Coma Survivor Story 00:25 Ebola Preparedness Reality 00:50 Curiosity And Risk 01:39 Show Intro And Guest 03:11 Near Death Malaria Lessons 05:16 How Vaccines Work 07:20 Why Malaria Vaccine Hard 09:40 Vaccine Platforms Evolution 12:00 mRNA Breakthrough Limits 13:40 Scaling Lab To Factory 15:59 Vaccine Supply Chain Map 19:16 Purification Cost Challenge 21:16 Quality By Design GMP 23:21 What Drives Vaccine Cost 24:44 Indigenous Manufacturing Push 28:45 Innovation Needs Buyers 30:11 Pandemic Supply Chain Gaps 33:08 Outbreak Response Together 34:19 Ebola Systems Not Just Vaccine 37:29 Cold Chain Never Break 38:34 Myth And Supply Chain 38:51 Rapid Fire Vaccine Takes 39:56 Purpose And The Five Whys 42:15 Politics And Vaccine Access 43:47 Disease X And Unknown Threats 44:49 Zero Dose Immunization Gap 46:50 Innovation Versus Last Mile 49:11 India Asia Manufacturing Rise 50:52 Tech Transfer Trust Explained 54:06 Future Of Biomanufacturing 55:53 Leading In Gray Space 01:03:17 Gen Z Purpose Discipline 01:05:32 Read Rooms Fix Systems 01:08:49 Ambi Polymer Healthcare Vision 01:11:03 Final Advice And Farewell #Vaccines #HealthcareInnovation #PandemicPreparedness #Biologics #imatalks Visit our social media pages: LinkedIn:   / published   Instagram:   / amipolymer   In this powerful episode of IMA TALKS, host Khushi Gandhi sits down with Dr. Priyabrata Pattnaik, CEO of Ami Polymer and a veteran in infectious disease research, bioprocessing, and vaccine development.

From surviving cerebral malaria and a life-changing coma at 19 in a remote tribal area, to leading critical components manufacturing for global biologics, Dr. Pattnaik shares a deeply personal and insightful journey at the intersection of science, resilience, and real-world impact.

Key Highlights:

• His near-death experience with malaria and why access to healthcare — especially the "last mile" — remains one of the biggest challenges in global health

• The evolution of vaccine platforms (from traditional inactivated vaccines to mRNA), manufacturing scale-up hurdles, purification challenges, and what truly drives vaccine costs

• Lessons from Ebola, COVID-19, and Disease X: Why in-country capacity, supply chain resilience, and balancing emergency response with routine immunization are critical for future preparedness

• Leadership wisdom for scientists and young professionals: The power of curiosity, asking "why," embracing gray spaces in decision-making, and staying true to your North Star

Dr. Pattnaik also discusses Atmanirbhar Bharat’s role in vaccine self-reliance, the promise and realities of new technologies, and practical advice for the next generation entering life sciences.

Whether you're a healthcare professional, student, policymaker, or simply curious about how science turns into lifesaving impact, this conversation offers profound takeaways on innovation, equity, and preparedness.

🎧 Listen now and discover what it really takes to build resilient health systems.

If you enjoyed this episode, like, subscribe to IMA Talks for more conversations where science meets story, and share it with someone passionate about healthcare and innovation. Turn on notifications so you never miss an episode!

00:00 Coma Survivor Story

00:25 Ebola Preparedness Reality

00:50 Curiosity And Risk

01:39 Show Intro And Guest

03:11 Near Death Malaria Lessons

05:16 How Vaccines Work

07:20 Why Malaria Vaccine Hard

09:40 Vaccine Platforms Evolution

12:00 mRNA Breakthrough Limits

13:40 Scaling Lab To Factory

15:59 Vaccine Supply Chain Map

19:16 Purification Cost Challenge

21:16 Quality By Design GMP

23:21 What Drives Vaccine Cost

24:44 Indigenous Manufacturing Push

28:45 Innovation Needs Buyers

30:11 Pandemic Supply Chain Gaps

33:08 Outbreak Response Together

34:19 Ebola Systems Not Just Vaccine

37:29 Cold Chain Never Break

38:34 Myth And Supply Chain

38:51 Rapid Fire Vaccine Takes

39:56 Purpose And The Five Whys

42:15 Politics And Vaccine Access

43:47 Disease X And Unknown Threats

44:49 Zero Dose Immunization Gap

46:50 Innovation Versus Last Mile

49:11 India Asia Manufacturing Rise

50:52 Tech Transfer Trust Explained

54:06 Future Of Biomanufacturing

55:53 Leading In Gray Space

01:03:17 Gen Z Purpose Discipline

01:05:32 Read Rooms Fix Systems

01:08:49 Ambi Polymer Healthcare Vision

01:11:03 Final Advice And Farewell

#Vaccines #HealthcareInnovation #PandemicPreparedness #Biologics #imatalks

Visit our social media pages:

LinkedIn:   / published  

Instagram:   / amipolymer  

]]> 4423 IMA Talks | Revolutionizing Biotech: A Conversation with Dr. Gadgil from Enzene In this episode of IMA Talks, powered by AMI Polymer, host Khushi Gandhi sits down with Dr. Gadgil, the CEO of Enzene, to explore how he's redefining the landscape of biotech and biomanufacturing. From his early interest in biology to his thriving career in the US, and his return to India to challenge biomanufacturing norms, Dr. Gadgil shares his inspiring journey. They discuss the evolution of continuous manufacturing, the significant role of single-use systems, and the broader impact on healthcare access and affordability. Additionally, the conversation delves into the challenges and successes of launching Enzene’s innovative platforms in both India and the US. This episode is a deep dive into vision, innovation, and the future of biotech, providing insights for entrepreneurs, industry professionals, and anyone passionate about science and innovation.   00:00 Introduction and Initial Thoughts 00:09 Early Interest in Biology 00:22 Vision for Biotech Leadership 00:51 Market Disruption and Innovation 02:07 Personal Journey and Career Decisions 05:59 Returning to India and Professional Goals 07:53 Building a Culture of Excellence 11:51 Continuous Manufacturing and Technological Advances 17:59 Single Use Systems and Sustainability 20:43 Future of Personalized Medicine 28:19 Expansion to the US and Strategic Decisions 34:57 Innovating Across Borders 35:24 The Importance of Intellectual Property 36:11 Keeping Up with New Modalities 36:32 The Idea Bubble: Fostering Innovation 39:26 Ayurveda Meets Modern Science 41:08 Cost and Scale in Biomanufacturing 44:54 Leadership and Team Dynamics 46:15 Rapid Fire Questions 49:39 Post-COVID Supply Chain Shifts Fri, 12 Sep 2025 12:30:00 -0000 full 1 1 AMI Polymers In this episode of IMA Talks, powered by AMI Polymer, host Khushi Gandhi sits down with Dr. Gadgil, the CEO of Enzene, to explore how he's redefining the landscape of biotech and biomanufacturing. From his early interest in biology to his thriving career in the US, and his return to India to challenge biomanufacturing norms, Dr. Gadgil shares his inspiring journey. They discuss the evolution of continuous manufacturing, the significant role of single-use systems, and the broader impact on healthcare access and affordability. Additionally, the conversation delves into the challenges and successes of launching Enzene’s innovative platforms in both India and the US. This episode is a deep dive into vision, innovation, and the future of biotech, providing insights for entrepreneurs, industry professionals, and anyone passionate about science and innovation.   00:00 Introduction and Initial Thoughts 00:09 Early Interest in Biology 00:22 Vision for Biotech Leadership 00:51 Market Disruption and Innovation 02:07 Personal Journey and Career Decisions 05:59 Returning to India and Professional Goals 07:53 Building a Culture of Excellence 11:51 Continuous Manufacturing and Technological Advances 17:59 Single Use Systems and Sustainability 20:43 Future of Personalized Medicine 28:19 Expansion to the US and Strategic Decisions 34:57 Innovating Across Borders 35:24 The Importance of Intellectual Property 36:11 Keeping Up with New Modalities 36:32 The Idea Bubble: Fostering Innovation 39:26 Ayurveda Meets Modern Science 41:08 Cost and Scale in Biomanufacturing 44:54 Leadership and Team Dynamics 46:15 Rapid Fire Questions 49:39 Post-COVID Supply Chain Shifts In this episode of IMA Talks, powered by AMI Polymer, host Khushi Gandhi sits down with Dr. Gadgil, the CEO of Enzene, to explore how he's redefining the landscape of biotech and biomanufacturing. From his early interest in biology to his thriving career in the US, and his return to India to challenge biomanufacturing norms, Dr. Gadgil shares his inspiring journey. They discuss the evolution of continuous manufacturing, the significant role of single-use systems, and the broader impact on healthcare access and affordability. Additionally, the conversation delves into the challenges and successes of launching Enzene’s innovative platforms in both India and the US.

This episode is a deep dive into vision, innovation, and the future of biotech, providing insights for entrepreneurs, industry professionals, and anyone passionate about science and innovation.

 

00:00 Introduction and Initial Thoughts

00:09 Early Interest in Biology

00:22 Vision for Biotech Leadership

00:51 Market Disruption and Innovation

02:07 Personal Journey and Career Decisions

05:59 Returning to India and Professional Goals

07:53 Building a Culture of Excellence

11:51 Continuous Manufacturing and Technological Advances

17:59 Single Use Systems and Sustainability

20:43 Future of Personalized Medicine

28:19 Expansion to the US and Strategic Decisions

34:57 Innovating Across Borders

35:24 The Importance of Intellectual Property

36:11 Keeping Up with New Modalities

36:32 The Idea Bubble: Fostering Innovation

39:26 Ayurveda Meets Modern Science

41:08 Cost and Scale in Biomanufacturing

44:54 Leadership and Team Dynamics

46:15 Rapid Fire Questions

49:39 Post-COVID Supply Chain Shifts

]]> 4319